One miscarriage is a disaster. Two is worse. Imagine the suffering of women who have 3, 5, 7 or even 12 pregnancy losses, and sometimes as late as the last few weeks of their pregnancy.
We now know that Hughes Syndrome is the most common treatable cause of recurrent miscarriage: depending on which study you quote, the figure is up to 1 in 5. Furthermore, late pregnancy loss, fortunately an unusual problem in pregnancy, is very strongly associated with Hughes Syndrome as is pre-eclampsia, placental abruption and intra-uterine growth restriction.
For the sake of a simple blood test, patients with miscarriage or late pregnancy loss can be tested for Hughes Syndrome. Treatment of these patients has proved one of the true successes of modern medicine, the successful pregnancy rate rising from a previous low of fewer than 20% to figures now in the region of 75-80% success rate. Treatment is with low-dose aspirin and/or heparin.
But there is more to this syndrome than just the heartbreak of multiple miscarriage:
Hughes Syndrome (APS) is sometimes called ‘sticky blood syndrome’. This is because people with it have an increased tendency to form clots in blood vessels (also known as thromboses). Any blood vessel can be affected including the veins and the arteries. Click here for a comprehensive snapshot.
The main symptoms of Hughes Syndrome can include any of the following:
Headache or migraine
Thrombosis – DVTs
Multiple Sclerosis-like features
That’s a pretty frightening list. And what’s more frightening, this disease has been found to be caused by Tetanus vaccines.
The tetanus vaccine causes a new disease known both as Hughes syndrome and antiphospholipid syndrome (APS). It’s an autoimmune condition that can attack any part of the body, though is best noted for heart attacks and killing fetuses. It’s likely that APS will become more common with the new generation of vaccine adjuvants now being produced.
The sufferers of (APS) are mostly women, and its diagnosis is often made as a result of multiple pregnancy losses. As is typical of new diseases, research is focused on finding a genetic cause, in spite of the fact that the connection with vaccines is well known and documented.
APS can also be diagnosed—more accurately, misdiagnosed—as lupus erythematosus, which is another vaccine-induced condition.
One study calls Hughes syndrome the “classical antiphospholipid syndrome”. That study refers to similarities between plasma protein beta-2-glycoprotein-I (β2GPI), which is attacked in APS, and the tetanus vaccine. That is, the tetanus antigen has parts that are virtually identical to β2GPI, which is found virtually everywhere in the body.
Another study documents how APS can be induced in laboratory animals with tetanus vaccination. Many large number of other studies document and investigate the connection between vaccines and antiphospholipid syndrome[3, 4, 5, 6, 7, 8].
These studies leave little doubt that APS is caused by vaccines. That should come as little surprise, since it was first identified as a disease during the 1980s. If this disease existed prior to vaccines, it was so rare that it was unknown. Now, it can take its place among a growing list of vaccine-induced conditions, including rheumatoid arthritis, macrophagic myofasciitis, multiple sclerosis, autism, and siliconosis. The list keeps growing and many believe that all these conditions should be included under a single name, autoimmune/inflammatory syndrome induced by adjuvants, or ASIA.
ASIA should also include Fibromyalgia, Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME), Chronic Myofascial Pain Syndrome [possibly another name for macrophagic myofasciitis] which also appeared in the 1980s. All have been treated as mental illnesses primarily, and the newest mental health guidelines continue to do so.
Antiphospholipid syndrome is an autoimmune disease, which has only recently been recognised and defined. It is the most common treatable cause of recurrent miscarriage.
So why are there adjuvants in vaccines at all?
Adjuvants were discovered by accident when it was noted that dirty—literally dirty, contaminated—vaccine containers produced better results in terms of a vaccine’s ability to create antibodies. It was literally the dirty secret of vaccinology, and led to the intentional contamination of vaccines. The contaminants were relabeled as adjuvants.
Of course, there are side effects to adjuvants. The one that became standard, aluminum, is a known toxin. But, as long as it made the vaccine more effective at producing antibodies, the toxic properties of aluminum were—and still are—swept under the rug.
Other adjuvants had been tried, but all were even more toxic. Among the very worst were ones based on oils, Freund’s adjuvants. These were quickly determined to be far too toxic for use in vaccines, though they did find another marketable use. Freund’s adjuvants are now routinely used in medical research because they create the equivalent of human autoimmune disorders, such as rheumatoid arthritis, in laboratory animals, which are then studied to find treatments for the human disorders.
Now they have found OMV adjuvants, which are being promoted as the safest yet. A recent report in Proceedings of the National Academy of Sciences (PNAS), discusses “a less toxic mixture of monophosphorylated lipid A species (MPL)” made through the OMV methodology. Notice that the emphasis is on “less toxic”.
The fallacious claim that OMV lipids are safe is based on their being natural. It’s that very fact, that they’re natural—literally analogs of normal body chemistry—that makes them so dangerous. Their injection can cause them to be seen as toxins—which, of course, in this context they are—which can result in antibodies being developed against chemicals that are naturally found in the body. An autoimmune disease is the body’s immune system turning on itself.
From one of the studies linked to the above article:
Using a mouse model, we showed that intraperitoneal injection of OMVs derived from intestinal Escherichia coli induced lethality. Furthermore, OMVs induced host responses which resemble a clinically relevant condition like sepsis that was characterized by piloerection, eye exudates, hypothermia, tachypnea, leukopenia, disseminated intravascular coagulation, dysfunction of the lungs, hypotension, and systemic induction of tumor necrosis factor-α and interleukin-6.
That sounds like a VERY painful death to me. And yet, THAT is what is now being used in vaccines for human infants.
What about “just” aluminum [Al ] as an adjuvant?
Studies have shown that many aluminum-containing vaccines cause higher and more prolonged antibody responses than comparable vaccines without the adjuvant. The benefit of adjuvants has usually been observed during the initial immunization series rather than with booster doses.1
There are three general types of aluminum-containing adjuvants:
Potassium aluminum sulfate (often called “Alum”)
The effectiveness of each salt as an adjuvant depends on the characteristics of the specific vaccine and how the manufacturer prepares the vaccine.3 To work as an adjuvant, the antigen must be adsorbed to the aluminum; that is, it is clumped with the aluminum salt to keep the antigen at the site of injection.4
Not all vaccines contain aluminum salts because an adjuvant may not have been needed, was not expected to increase the desired immune response, or was going to cause an imbalance in the immune response. For example, inactivated Polio Virus (IPV) vaccine, measles, mumps and rubella vaccine (MMR), varicella vaccine, Meningococcal conjugate (MCV4) vaccine, and influenza vaccines do not contain aluminum salts.2
The US licensed vaccines for children that contain aluminum adjuvants are 3:
DTP (diphtheria-tetanus-pertussis vaccine)
DTaP (diphtheria-tetanus-acellular pertussis vaccine)
Some but not all Hib (Haemophilus influenzae type b) conjugate vaccines
Pneumococcal conjugate vaccine
Hepatitis B vaccines
All combination DTaP, Tdap, Hib, or Hepatitis B vaccines
Hepatitis A vaccines
Human Papillomavirus vaccine
Inactivated Polio Virus (IPV) vaccine, measles, mumps and rubella vaccine (MMR), varicella vaccine, and influenza vaccines do not contain aluminum salts.
The very same article went on to say:
Macrophagic myofasciitis (MMF) is a term that is used to describe some findings that have been seen microscopically in some muscle biopsies. The lesions are thought to be caused by tissue changes resulting from the normal immune response to the aluminum-adsorbed vaccine. 9
The biopsy findings were originally described in a group of French adult patients who had muscle and joint aches and pains and fatigue.10 Although France is the exception, biopsies of muscle are not usually performed on muscles of the arm because that is where vaccines and other shots are often given. In addition, because muscle biopsies are quite painful, muscle biopsies are not performed on normal people—that is, there are no normal control muscle biopsies with which to compare the French patients’ biopsies.
Although the physician who first described the biopsy findings proposed that the aluminum-containing vaccines caused the symptoms in his patients10, most scientists believe that the tissue findings showed the normal response to the aluminum adjuvant; and many felt that the patients’ illnesses did not warrant the performance of a muscle biopsy. 11
Why would the vaccine producers be doing this to us? Why would governments allow, even demand, this be done to children?
Population is growing at a rapid pace in many economically developing countries and there is a continuing need of an alternate method for regulation of fertility. We proposed several years back a birth control vaccine which induces the formation of antibodies against the human pregnancy hormone, the human chorionic gonadotropin (hCG). These inventions are described in patents issued in India, U.S.A. and several other countries. (Ref. EP 204566, JP 62286928, CA 1239346, U.S. Pat. No. 4,780,312, CN 8603854). We describe now another invention which generates antibody response of a long duration against hCG after a single or a limited number of injections.
Whereas the possibility of controlling fertility by raising antibodies against hCG is known from our previous studies and those of others, the vaccines utilized earlier were conjugates of two or more peptides such as the natural beta hCG peptide of 145 amino acids linked to tetanus toxoid or other carriers.
It is their INTENT to make girls and women allergic to human chorionic gonadotropin (hCG), the pregnancy hormone.
The anti-fertility vaccines that are being researched refer to the mode of action of conventional vaccines against diseases. They are based on the stimulation of the immune system, but unlike anti-disease vaccines which target foreign substances, anti-fertility vaccines evoke antibodies against the body s own substances like molecules. As a result, the body s self-protection is reprogrammed to attack targets the body normally tolerates. To that end, the targeted, normally tolerated molecule, has to be linked to a foreign protein, rendering the entire product foreign and inducing an antibody reaction.
Currently six variations of these vaccines are at different stages of development. Commonly identified as the most suitable candidates for vaccine development are certain molecules on the surface of the sperm and the egg, molecules on the surface of the fertilized egg and the early embryo, and human chorionic gonadotrophin (hCG). The hormone hCG is secreted by the surface of the early embryo to remain implanted in the womb. If hCG is blocked, the level of progesterone declines and the blastocyst (fertilized egg 5 days after fertilization) is expelled, thereby terminating the pregnancy. Anti- hCG vaccine consists of a part of the hormone linked to a bacterial or viral carrier inducing the antibody reaction. However, researchers admit that it is not known exactly how immunization against hCG impairs fertility.
The prototype version of an anti-hCG vaccine consist of an immunogen, formed from a (synthetic) peptide of hCG conjugated to a toxoid carrier molecule, mixed with an immunostimulant, and suspended in a fluid vehicle.
Other more advanced approaches that have reached clinical trials are vaccines inhibiting the gonadotrophin-releasing hormone (GnRH), produced within the diencephalon. The diencephalon (hypothalamus) is a part of the brain that lies beneath the thalamus where the flow of steroid hormones is regulated. The hormone is involved in the fine-tuning of these steroid hormones. Because this vaccine, developed by the Population Council, brings the hormonal cascade to a total standstill both male and female recipients need synthetic steroid hormone replacement in order to counteract unwanted side-effects such as the loss of bone density. In women a reaction similar to an artificial menopause is induced.
The first clinical trials with anti-fertility vaccines began in the 1970s. Until early 1994, about 400 experimental subjects, mainly women, were involved. By far the most researched and clinical tested are anti- hCG vaccines. Two prototypes, developed by National Institute of Immunology (NII) and the Special Programme of Research, Development and Research Training in Human Reproduction (HRP), are being tested on women in India, Australia, Brazil, Chile, Dominican Republic, Finland and Sweden. The NII has started experiments with live vectors. In order to prolong antibody response, beta- hCG genes were transferred into a vaccinia virus, which reproduces itself. The stability of the vaccinia, pathogen of cowpox, is controversial.
Abuse. Due to the lack of user control, the approach also bears a high potential for abuse. The method might encourage efforts to control female fertility for demographic purposes as it is easy for medical or paramedical staff to administer without a woman s full knowledge or consent. The design of anti-hCG vaccines allows the antagonist to be coupled with vaccines against diseases, i.e. diphtheria, tetanus or measles. As admitted at the 1989 WHO-Symposium, due to this potential for abuse, the method might even discredit health care and general vaccination programmes conducted in countries of the South.
Duration. It is generally assumed that the final product will be a anti-fertility vaccine, administered by injection or orally and lasting for one to two years. Once the treatment is administered it cannot be discontinued and women or men affected must wait until the immunological effect decreases. Though the WHO/HRP is considering counter-vaccines to “switch on” fertility if required, nothing concrete has been researched so far. In fact, when and whether fertility is regained depends not only on the individual immune response, but also on the ethnic response. Within the scientific community there is debate about irreversibility and thus “non-surgical sterilization” as appreciated effect.
Working. Clinical trials with women have shown that the differences in immune response is not only relevant concerning reversibility but for the effectiveness of the contraceptive as well. Thus it is reported that women in clinical trials with the Indian made prototype conceived and some even gave birth to children. Yet nothing is known about the possible ill-effects on the children of these vaccinated women, and no research on this is being carried out.
So, humanity has been subjected to birth control. Without our knowledge or consent. And many of us are heartbroken trying to have children when our bodies have been programmed to kill them. Many more have serious illnesses that leave us crippled and in pain. Just because some arrogant elitists wanted to reduce our birth rate.